ArticleBMC endocrine disorders2026
Coronary artery calcification in Type 2 diabetes mellitus: biochemical and inflammatory insights from the Pakistani Population - a case-control study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with Type 2 diabetes mellitus (T2DM) are at increased risk of atherosclerotic cardiovascular disease, and coronary artery calcium score (CACS) serves as an important tool for cardiovascular risk assessment in this population. This study examines the correlation of CACS with biochemical and inflammatory parameters in individuals with T2DM.
methodsThis case-control study was conducted at Baqai Medical University and comprised 184 individuals with T2DM and 184 healthy people. CACS was assessed with cardiac non-contrast computed tomography. The Agatston method was used to determine CACS, while biochemical markers, such as lipid profiles and HbA1c, were analyzed using enzymatic colorimetric method and high-performance liquid chromatography. Inflammatory parameters, including hs-C reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF- α) were measured using immunoassays.
resultsSignificant differences were observed in median values of age (p < 0.0001), HbA1c (p < 0.0001), cholesterol (p = 0.001), triglycerides (p < 0.0001), hs-CRP (p < 0.0001), and IL-6 (p < 0.0001) in persons with T2DM compared to healthy subjects. Individuals with T2DM exhibited significantly higher CACS in both mild to moderate (1-100) and moderate to severe (> 100) categories compared with healthy controls (p-value < 0.0001). The CACS positively correlated with age (p < 0.0001), HbA1c (p < 0.0001), and low-density lipoprotein levels (p = 0.041). Binary logistic regression showed that elevated HbA1c and hs-CRP were independent predictors of coronary artery calcification in T2DM patients. Other factors, including age, BMI, family history, and lipid levels, were not significant after multivariate adjustment.
conclusionPoor glycemic control and systemic inflammation, reflected by elevated HbA1c and hs-CRP, are key independent predictors of calcified coronary arteries in patients with T2DM, underscoring importance of targeting hyperglycemia and inflammation to reduce cardiovascular risk.
trial registrationClinical trial no. not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.